Canaccord Genuity Raises Price Target on AT&T (T) Following 2Q15

AT&T (T) PT Bumped to $39 at Macquarie

Macquarie analyst Kevin Smithen bumped his price target on Outperform-rated AT&T (NYSE: T) to $39.00 (from $38.00) after updating forecasts for Q2 results and for the closing of the DTV deal on Friday.

Smithen commented, "Based on our recent marketing trip, we believe many investors... More

Goldman Sachs Reinstates AT&T (T) at Neutral

Goldman Sachs reinstated coverage on AT&T (NYSE: T) with a Neutral rating and a price target of $37.00.

For an analyst ratings summary and ratings history on AT&T click here. For more ratings news on AT&T click here.

Shares of AT&T closed at $34.29 yesterday.

AT&T (T) Announces Completion of DIRECTV Acquisition; DIRECTV CEO White to Retire

AT&T (NYSE: T) has completed its acquisition of DIRECTV. The newly combined company the largest pay TV provider in the United States and the world will offer millions of people more choices for video entertainment on any screen from almost anywhere, any time.

"Combining DIRECTV with AT&T is all about giving customers more choices for great video entertainment integrated with mobile and high-speed Internet service," said Randall Stephenson, AT&T chairman and CEO. "We'll now be able to meet consumers' future entertainment preferences, whether they want traditional TV service with premier... More

FCC Grants Approval of AT&T (T), DIRECTV (DTV) Deal

(Updated - July 24, 2015 2:34 PM EDT)

FCC grants approval of AT&T (NYSE: T) and DIRECTV (NASDAQ: DTV) deal.

Note: The dedicated FCC site for the transaction is here.

UPDATE - The press release follows:

Today, the Federal Communications Commission grants with conditions approval of the transfer of control of licenses and authorizations from DIRECTV to AT&T Inc. (AT&T). The approval will allow AT&T to acquire... More

Pre-Open Stock Movers 07/24: (SFG) (AMZN) (ITEK) Higher; (SNSS) (TRUE) (BIIB) Lower (more...)

Sunesis Pharmaceuticals (NASDAQ: SNSS) 60.8% LOWER; announced regulatory updates from its interactions with the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) regarding a potential path toward marketing... More

After-Hours Stock Movers 07/23: (AMZN) (P) (V) (SBUX) Higher; (SNSS) (TRUE) (TRIP) Lower (more...)

Sunesis Pharmaceuticals (NASDAQ: SNSS) 60.8% LOWER; announced regulatory updates from its interactions with the European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) regarding a potential path toward marketing authorization for vosaroxin as a treatment for acute... More

FCC's Mike O'Rielly Comments After Voting on AT&T (T), DIRECTV (DTV) Merger

FCC Commissioner Mike O'Rielly said he voted on AT&T's (NYSE: T) proposed merger with DIRECTV (NASDAQ: DTV).

"After reading the Order as prepared by Commission staff, reviewing the voluminous record in the proceeding, and listening... More

Market Wrap: Initial Claims Slip to 42-Year Low; Ferrari Revs-up Its IPO; Splitsville for Pearson, FT Group

Market wrap for July 23rd

End of the Day: S&P 500 down 12.0 to 2,102.15; Dow Jones down 119.1 to 17,731.92; Nasdaq down 25.4 to 5,146.41

Market Brief: Several Dow Jones Industrial Components (AmEx, Dow, and Caterpillar) pressured the index following quarterly results issued last night and this morning. News comes following Apple weighing down the Nasdaq on Wednesday following its C3Q15 report.

U.S. initial jobless claims... More